Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gabapentin in Patients at Clinical Risk for Psychosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02557945
Recruitment Status : Suspended (This study is temporarily suspended due to COVID-19)
First Posted : September 23, 2015
Last Update Posted : February 25, 2021
Sponsor:
Information provided by (Responsible Party):
Scott Small, New York State Psychiatric Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : May 31, 2022